Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 08-2015 | 08-2014 | 08-2013 | 12-2012 | 08-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,229 | 1,778 | 2,288 | N/A | 4,447 |
| Marketable Securities | 14,016 | 19,528 | 6,203 | N/A | 655 |
| Receivables | N/A | 408 | 63 | N/A | 85 |
| TOTAL | $17,372 | $21,778 | $8,644 | $N/A | $5,277 |
| Non-Current Assets | |||||
| PPE Net | 11 | 14 | 6 | N/A | 5 |
| Investments And Advances | 8,962 | 3 | 5 | 0 | 9 |
| Other Non-Current Assets | 9 | 7 | 5 | 0 | 5 |
| TOTAL | $8,982 | $24 | $16 | $N/A | $18 |
| Total Assets | $26,354 | $21,802 | $8,660 | $N/A | $5,295 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 989 | 973 | 498 | 0 | 644 |
| TOTAL | $1,489 | $973 | $498 | $N/A | $644 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 500 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 37 | 36 | 31 | 0 | 872 |
| TOTAL | $37 | $36 | $31 | $N/A | $872 |
| Total Liabilities | $1,526 | $1,009 | $529 | $N/A | $1,517 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 86,505 | N/A |
| Common Shares | 138 | 121 | 95 | N/A | 80 |
| Retained earnings | -35,052 | -27,820 | -22,124 | N/A | -17,892 |
| Other shareholders' equity | 558 | 452 | 304 | 0 | 0 |
| TOTAL | $24,828 | $20,793 | $8,131 | $N/A | $3,778 |
| Total Liabilities And Equity | $26,354 | $21,802 | $8,660 | $0 | $5,295 |